People you know
Work you trust

Curta is a research partner specializing in evidence generation to support Health Policy, Market Access, Medical Affairs, and Commercialization in healthcare.

Evidence and analysis to solve the toughest problems in healthcare

With over 30 years of experience and leadership from world-class experts, Curta partners with biopharma companies to generate evidence through economic modeling, real-world data, evidence synthesis, and digital health strategies—helping demonstrate product value and inform access decisions worldwide.

Expertise

Curta’s leadership has 3 decades of experience and 1,500+ peer-reviewed papers and reports. A senior partner personally oversees the success of every project alongside a multidisciplinary team of experts including health economists, clinicians, and data scientists.

Collaboration

We support small biotech up through top 10 biopharma, and throughout the product lifecycle. Collaboration of Curta’s partners with the communities that create HTA and evidence-based guidelines brings real-world perspective on how to turn HEOR research into meaningful policy-changing evidence.

Innovation

Curta’s partners have been at the forefront of methods to measure and communicate value. As a fully partner-owned company, we prioritize innovative research and nimble problem solving to provide the right evidence at the right time.

Meet Curta

Curta's leadership has more than 30 years in the industry and have been pioneers in establishing and advancing the field. Curta boasts two former ISPOR presidents, innovative thinkers bringing new methods of measuring value, and a top-tier team of scientists to bring the highest level of quality and integrity to all of our client engagements.

About

I am a heading

Here goes your text … Select any part of your text to access the formatting toolbar.

Button Label

Our Expertise

Curta presently has an emphasis on early and HTA-compliant modeling, real-world evidence, evidence synthesis (SLR, ITC), and evidence generation to meet global reimbursement requirements, including evidentiary needs to support Medicare price negotiation.

I am a heading

Here goes your text … Select any part of your text to access the formatting toolbar.

Button Label
Economic Models
Population Impact Models
Mixture Cure Models
Oncology Simulation Model
Real Option Value
Real World Evidence
Medicare IRA Evidence Generation and Strategic Support
Health Technology Assessment Strategy & Support
Evidence Synthesis & Indirect Treatment Comparisons
Digital Health
United States Payer Tools and Dossiers

I am a heading

Here goes your text … Select any part of your text to access the formatting toolbar.

Button Label

"The model looks amazing and works really well. One of the easiest models I have ever used (usually I don’t really enjoy using them because the interface is annoying and stress-inducing). We are very pleased"

Executive Director, HEOR

"The model is beautiful"

Director, US Medical

"We are so glad we worked with you!"

Director, Market Access

"This is the best 1st draft paper I’ve received from a vendor during my almost 20 years. Congratulations, very happy."

Senior Director, Global Health Economics and Outcomes Research

"You guys do things really well... We have other vendors who are 'favorites' who have created BIMs with countless bugs, which hasn't been the case with you at all. Your BIM functions exactly as it should."

Head of Field Value & Market Access

"In the 20 years I have worked in industry, Curta is the best research partner I have ever worked with"

Senior Director Global Health Economics and Outcomes Research

Expertise

Collaboration

Innovation